Home > Insider Trading > Filing (0001493152-15-006113)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
868278	Prophase Labs Inc.	PRPH	Pharmaceutical Preparations (2834)	232577138

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1459632	S Mark Leventhal	621 N. Shady Retreat Road Doylestown PA 18901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	Acquisiton	2015-11-24	18,500	$1.30	850,480	No	4	P	Direct
Common Stock, Par Value $0.0005	Acquisiton	2015-11-25	17,252	$1.30	867,732	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 25, 2015.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.